ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Consolidation Unlikely to Save Money

December 17, 2010

Zerhouni Appoints Two Institute Directors

September 13, 2002

Also Coltman to step down as SWOG chairman, Baker is chairman-elect.

July 25, 2003

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

May 18, 2007

National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms

May 26, 1995

NCA Okays Only A committee For Centers, Not New Division

May 29, 1987